Showing results (31-40 of 50) with videos related to
Sort By:
Pageof 5
Acta Oncologica (Stockholm, Sweden)|October 4, 2011
Minor changes in effective half-life during fractionated 177Lu-octreotate therapyUlrike Garske, Mattias Sandström, Silvia Johansson, et al.Cancer Research|January 11, 2007
[177Lu]pertuzumab: experimental therapy of HER-2-expressing xenograftsMikael Persson, Lars Gedda, Hans Lundqvist, et al.European Journal of Nuclear Medicine and Molecular Imaging|February 6, 2007
Immuno-PET of undifferentiated thyroid carcinoma with radioiodine-labelled antibody cMAb U36: application to antibody tumour uptake studiesMarc-André Fortin, Alexei V Salnikov, Marika Nestor, et al.Cancer Biotherapy & Radiopharmaceuticals|October 27, 2005
In vitro characterization of 211 At-labeled antibody A33--a potential therapeutic agent against metastatic colorectal carcinomaYlva Almqvist, Anna Orlova, Anna Sjöström, et al.Cancer Biotherapy & Radiopharmaceuticals|October 25, 2002
Comparative biodistribution of the radiohalogenated (Br, I and At) antibody A33. Implications for in vivo dosimetryAnna Orlova, Johanna Höglund, Mark Lubberink, et al.Cancer Biotherapy & Radiopharmaceuticals|September 25, 2003
Early effects of low dose-rate radiation on cultured tumor cellsJörgen Carlsson, Emma Håkansson, Veronika Eriksson, et al.Theranostics|July 7, 2012
Lessons on Tumour Response: Imaging during Therapy with (177)Lu-DOTA-octreotate. A Case Report on a Patient with a Large Volume of Poorly Differentiated Neuroendocrine CarcinomaUlrike Garske, Mattias Sandström, Silvia Johansson, et al.Oncology Reports|March 29, 2007
Biodistribution of 211At labeled HER-2 binding affibody molecules in miceAnn-Charlott Steffen, Ylva Almqvist, Ming-Kuan Chyan, et al.British Journal of Haematology|March 5, 2003
Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomographySoheir Beshara, Jens Sörensen, Mark Lubberink, et al.Cancer Biotherapy & Radiopharmaceuticals|September 25, 2003
[(111)In]Bz-DTPA-hEGF: Preparation and in vitro characterization of a potential anti-glioblastoma targeting agentAsa Liljegren Sundberg, Anna Orlova, Alexander Bruskin, et al.Pageof 5